Sunrise Oncology Partners
233 Spring Street
New York, NY 10013
P: (212) 123­1223
F: (212) 123­1224
Patient Nam e:  Mott, Elizabeth 
Patient Number: 12345678Date: 06/18/2018
Date Of Birth:   08/29/1960
Date Details Outcome Comment
5/1/2018 Other Therapies Synthroid 175 mcg tablet Active
5/1/2018 Other Therapies Zoloft 50 mg tablet Active
Allergies
No known allergies have been entered for this patient.
Medical and Surgical History
Hypothyroidism. Mild anxiety.
Date Type ICD­9 ICD­10 Problem Comment Status
Date Type Details Outcome Comment
9/18/2018 Surgery Tonsillectomy 1960s
Social History
Patient 
is married.  No history of tobacco use.  Mrs. Mott reports the following support system: lives with family. Her diet consists of 
regular meals. She indicates her daily activity lev
el as: daily activities.
Alco
ho
l Use Yes, Weekly.
Family History
Reviewed and unchanged.
Gyn History
Menarche at the age of 12. LMP more than 10 years ago.
Review 
Of Systems
Constitu
tional Symptoms: Patient reports:  mild fatigue,  no weakness,  no weight loss,  no fevers,  no chills, no diaphoresis,  no night 
sweat s , no hot flashes.  exertional dyspnea, no cough
Eyes: Patient offers no eye complaints. 
Gastrointestinal : no nausea,  no vomiting,  no dysphagia,  no abdominal  pain, diarrhea, no constipation
Musculoskeletal: bone pain,  no back pain,  no arthralgia  
Integumentary: Patient reports: no rash, no pruritis, no skin lesions, no dry skin
Page 1 of 2  
FOLLOW UP VISIT
Chief Complaint
Mrs. Mott is a 57 year old woman who was diagnosed with breast c ancer in April 2018. She was found to have extensiv e 
bone metastases, adenopathy and hepatic lesions. Tumor was biopsied showing ER positive, P R positive, Her2 am plified 
breast cancer. Sy stemic treatment was initiated 5/8/18 with paclitax el, trastuzumab and pertuzumab. She has tolerated 
therapy well. Modest fatigue and mild diarrhea/loose bowel movements. She has not had fever or clinical signs of infection.  
She returns today for consideration of cycle 3.
On-going Treatment EventsNeurological: Patient reports: no headache, no peripheral neuropathy, no focal weakness, no tremor, no altered consciousness, n
oseizures, no speech impairment, no dizziness.  no paralysis,  nervousness
Vital Signs
V
itals on 6/18/18  12:59:00 PM: Height=66 in, Weight=155lb, Pulse=74 , Syst olicBP=122, DiastolicBP=68  
P
hysical 
G
eneral: P atient appears:   well developed and well n ourished, No alopecia noted.  
Eyes: No scleral icterus, and/or pallor. Conjunctiva clear. EOMs intact. Pupils equal and reactive to light. 
Cardio
vascular:  Heart with regular rate and rhythm. Normal S1 and S2. S3, S4 No gallop. No rubs or clicks. No bruits. Pedal pulses  
present. 
Ch
est: Clear no 
rales/rhonchi. No dullness to percussion. No wheezing. Chest wall expansion normal. No chest wall tenderness. No  
stridor. 
Abdo
men: Soft. Non­tender. Non­distended. No palpable masses. No ascites. No hepatosplenomegaly. Bowel sounds present in all 
quadrants. 
No hernia. 
Hematologic/
Lymph
atic: No cervical lymphadenopathy. No supraclavicular lymphadenopathy. No axillary lymphadenopathy. No inguinal  
lymphadenopathy. No petechiae. No ecchymosis. 
Skin
: No rashes. No lesions.  Extremities appear normal. No evidence of cyanosis.  No edema.  No clubbing present. 
Neurologic:  Alert and oriented.  Normal speech.  Cranial nerves in tact.  
Genitourinary:  Examination deferred.  
Rectal: E
xamination deferred.  
Gyn
ecological:  Examination deferred.
Laboratory Results
Lab results on 6/18/2018: Sodium=135 mmol/L, Potassium=4.2 mmol/L, CO2=31 mmol/L, Chloride=99 mmol/L, Glucose=84 mg/dL, 
Calcium=9.0 mg/dL, BUN=14 mg/dL, Creat=1.1 mg/dL, Alk Phos=45 U/L, ALT=21 U/L, AST=23 U/L, Total Bili=0.9 mg/dL, Albumin=3.7g 
dL, Total Protein=7.5 g/dL. WBC=4.1 x10E3/uL, RBC=4.63 x10E
6/uL, HGB=9.9 g/dL, HCT=31.4%, MCV=68 fL, MCH=21.4 pg, 
MCHC=31.5 g/dL, RDW=16.1 %, Plat=179 x10E3/uL, ANC=2.8 x10E3/uL, Lymph#=1.0 x10E3/uL, MONO#=0.2  x10E3/uL, BASO#=0.1 
x10E3/uL, EOS#=0.1 x10E3/uL, MONO%=5 %, BASO%=1 %, EOS%=1 %, Neut%=68 %
I
magi
ng Results
Radiology results were reviewed and discussed with the patient, including 4/2018-  MRI Brain no metastasis deep white matter changes 
suggestive of inflammatory process. PET/CT - left breast mass; diffuse bone metastases; liver lesions suspicious for metastatic breast 
cancer.
Primary Dx 
198.5 - Secondary malignant neoplasm of bone and bone marrow, Diagnosed Apr 2018
174.9 - Malignant neoplas
m of breast (female), unspecified site, Diagnosed Apr 2018
Assessment
Stage 
4 ER HER2 positive breast cancer with bone and liver metastases. Patient had a negative brain MRI.  Testing of tumor 
demonstrates ER+ PR+. HER2neu equivocal on IHC. FISH positive. Diagnostic data reviewed. CBC results from today  reviewed and 
compared to 5/8/18 and 5/29/18. Normal white count, hemoglobin, platelet count. Kidney function normal as well. Proceed today with 
cycle 3 TH plus pertuzumab. 
Patient seen by dentist last week. Begin Zoledronic acid with plans to administer treatment every three months. Immodium for treatment 
of diarrhea. 
Husband present with patient for support. 
Recommend
ation/Plan
Time spent with patient was  30 minutes. Over half the time was spent counseling and coordinating care, which included the  
foll
owing:
Reviewed with patient  treatment side effects.
Supportive 
measures reviewed.
Taxol, Herceptin and Perjeta. ZA
All quest
ions answered
Page 2 of 2  Electronically signed:DATE Jun 18, 2018  
TIME 1:34PM  
Shannon Wu, M.D.
